Nasdaq
NGNE
Neurogene Inc.
- Health Care
- Canada
- Listed 2014
- 1 day
- −1.1%
- 1 month
- −3.3%
- 1 year
- +67.2%
$35.60 · Mkt cap $681M
At the 6 Aug 2026 close
Nasdaq
Neurogene Inc.
$35.60 · Mkt cap $681M
At the 6 Aug 2026 close
Neurogene Inc. trades under the ticker NGNE on Nasdaq, in the Health Care sector (Biotechnology: Pharmaceutical Preparations). It has been listed since 2014. Its market capitalisation is $681M. The last closing price was $35.60, on 6 Aug 2026. No price-to-earnings ratio is shown, because it did not report positive earnings in its last annual filing. Over the past year the share price is +67.2%, and −3.3% over the past month. Returns are price returns and exclude dividends.
This page exists because NGNE is one of the shares What A Share can show you. It is not a recommendation, and its appearance here says nothing about whether the company is worth owning.